Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechan...

Por Kirchin, M A, Lorusso, V, Pirovano, G
Publicado no Br J Radiol (2015)

KEYnet: a keywords database for biosequences functional organization.

Por Licciulli, F, Catalano, D, D'Elia, D, Lorusso, V, Attimonelli, M
Publicado em 1999

Methodological assessment of HCC literature

Por Daniele, G., Costa, N., Lorusso, V., Costa-Maia, J., Pache, I., Pirisi, M.
Publicado em 2013

A six-year retrospective analysis of cut-out risk predictors in cephalomedullary nailing for pertrochanteric fractures: Can the tip-apex distance (TAD) still be considered the best...

Por Caruso, G., Bonomo, M., Valpiani, G., Salvatori, G., Gildone, A., Lorusso, V., Massari, L.
Publicado no Bone Joint Res (2017)

Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma

Por Azzariti A, Brunetti O, Porcelli L, Graziano G, Iacobazzi RM, Signorile M, Scarpa A, Lorusso V, Silvestris N
Publicado em 2016-07-01

Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma

Por Comella, P, Farris, A, Lorusso, V, Palmeri, S, Maiorino, L, Lucia, L De, Buzzi, F, Mancarella, S, Vita, F De, Gambardella, A
Publicado em 2003

Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective – prospective observational study –...

Por Hoefeler, H., Duran, I., Hechmati, G., Garzon Rodriguez, C., Lüftner, D., Ashcroft, J., Bahl, A., Atchison, C., Wei, R., Thomas, E., Lorusso, V.
Publicado no J Bone Oncol (2014)

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients

Por Comella, P, Casaretti, R, Crucitta, E, De Vita, F, Palmeri, S, Avallone, A, Orditura, M, De Lucia, L, Del Prete, S, Catalano, G, Lorusso, V, Comella, G
Publicado em 2002

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and...

Por Aapro, M., Rugo, H., Rossi, G., Rizzi, G., Borroni, M. E., Bondarenko, I., Sarosiek, T., Oprean, C., Cardona-Huerta, S., Lorusso, V., Karthaus, M., Schwartzberg, L., Grunberg, S.
Publicado em 2014

Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study

Por Adamo, V, Lorusso, V, Rossello, R, Adamo, B, Ferraro, G, Lorusso, D, Condemi, G, Priolo, D, Di Lullo, L, Paglia, A, Pisconti, S, Scambia, G, Ferrandina, G
Publicado em 2008

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

Por Cappuzzo, F, Novello, S, De Marinis, F, Franciosi, V, Maur, M, Ceribelli, A, Lorusso, V, Barbieri, F, Castaldini, L, Crucitta, E, Marini, L, Bartolini, S, Scagliotti, G V, Crinò, L
Publicado em 2005

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

Por Lorusso, V, Crucitta, E, Silvestris, N, Catino, A, Caporusso, L, Mazzei, A, Guida, M, Latorre, A, Sambiasi, D, D'Amico, C, Schittulli, F, Calabrese, P, De Lena, M
Publicado em 2003

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?

Por Cazzaniga ME, Biganzoli L, Cortesi L, De Placido S, Donadio M, Fabi A, Ferro A, Generali D, Lorusso V, Milani A, Montagna E, Munzone E, Orlando L, Pizzuti L, Simoncini E, Zamagni C, Pappagallo GL
Publicado em 2019-04-01

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines

Por Berruti, A, Bitossi, R, Gorzegno, G, Bottini, A, Generali, D, Milani, M, Katsaros, D, Rigault de la Longrais, I A, Bellino, R, Donadio, M, Ardine, M, Bertetto, O, Danese, S, Sarobba, M G, Farris, A, Lorusso, V, Dogliotti, L
Publicado em 2005

A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-posi...

Por De Placido, S, De Laurentiis, M, De Lena, M, Lorusso, V, Paradiso, A, D'Aprile, M, Pistillucci, G, Farris, A, Sarobba, M G, Palazzo, S, Manzione, L, Adamo, V, Palmeri, S, Ferraù, F, Lauria, R, Pagliarulo, C, Petrella, G, Limite, G, Costanzo, R, Bianco, A R
Publicado em 2005